Effects of Mixed Spices on Cardiometabolic Function - the PolySPice (PSP) Study (PSP)

October 9, 2018 updated by: JeyaKumar Henry, Clinical Nutrition Research Centre, Singapore
The study will investigate whether having mixed spices rich in polyphenols can improve postprandial cardiometabolic response in healthy Chinese men.

Study Overview

Detailed Description

Spices have been used for centuries to enhance food flavouring and to maintain health. Use of spices as a culinary ingredient is common amongst people of all ethnicities within South and East Asia. Spices are also one of the main sources of polyphenols in the Asian diet. Several in vitro studies and some in vivo studies, mainly in animals have shown that individual spices, including turmeric (containing curcumin), cinnamon (cinnimic acid), ginger, garlic etc. have been shown to improve glucose and lipid metabolism.However, well-controlled randomised trials, within the normal dietary context in humans are limited.

This study will be conducted using a three-way randomised crossover design using the Latin square approach. In the two treatment sessions, each volunteer will consume a mixed spice dish at two doses (i.e., 'small portion' or 'large portion' curry sauce), and rice as the base ingredient. In the control session, the same base ingredient (rice) but without the mixed spices will be served. The total amount of mixed spices consumed, to be made from dried powders of turmeric, cumin, coriander, gooseberry (amla), cinnamon, clove and cayenne pepper, will be 6 g and 12 g for small and large portion curries respectively. In addition, as added vegetables, the curry meals will contain tomato, garlic, onion and ginger, whereas the control meal will just have tomato and peeled aubergine, although, the total amount of vegetables will remain the same across all dishes (treatment or control).

The primary objective of this study will be to measure postprandial and fasting changes in blood glucose, insulin, triglycerides (TG), free fatty acids (FFA), 24h ambulatory blood pressure (BP), endothelial function and inflammatory markers following consumption of increasing doses of mixed spices in a single meal, on separate occasions.

The secondary objective of the study will be to monitor changes in blood levels of gut hormones, plasma and urine metabolome including polyphenols such as benzoate and hippurate, gut microflora content and function, as a result of the mixed spice intake. A subset of the treatments (control and high spice dose only) will also have interstitial glucose monitored continuously for a period of up to 3 days using the continuous glucose monitoring system (CGMS).

Study Type

Interventional

Enrollment (Actual)

33

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Singapore, Singapore, 117599
        • Clinical Nutrition Research Centre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 40 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Chinese Male
  • Age between 21 to 40 years
  • Body Mass Index between 18.5 to 27.5 kg/m2
  • Waist circumference ≤ 90cm
  • Fasting blood glucose < 6.0mmol/L
  • Blood pressure <140mmHg systolic or < 90mmHg diastolic
  • Do not partake in sports at the competitive and/or endurance levels and willing to stop any strenuous activity during or within 72 hours of test days

Exclusion Criteria:

  • Smoking
  • Allergic/intolerant to any of the test foods mentioned above, or any of the following common food and ingredients: eggs, fish, milk, peanuts, and tree nuts, shellfish, soya, wheat, gluten, cereal, fruits, dairy products, meat, vegetable, sugar and sweetener, natural food colourings or flavourings, etc.
  • Have difficulty passing motion
  • Have or had diarrhea in the past 1 month of study participation
  • Have any metabolic or cardiovascular diseases (e.g., diabetes, heart condition) or any other diseases involving the small intestine or the colon (e.g., irritable bowel syndrome, inflammatory bowel disease, gastric reflux) Have any liver or kidney disorders or any family history of kidney stones
  • Taking any prescribed medication or dietary supplements which may interfere with the study measurements, including consumption of probiotic drinks or supplements, taking antibiotics, laxatives or antidiarrheal medicines likely to interfere with study findings
  • Excessive alcohol consumption: consuming alcohol on > 4 days per week with ≥ 6 alcoholic drinks per week
  • Individuals who have donated blood within the previous 6 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Rice with vegetables but no added spice
Control session - rice with control vegetables (tomatoes and aubergines) - no mixed spices
Dose 0
Active Comparator: Rice with vegetables and low spice
Dose 1 mixed spice session - rice with 6 g powdered mixed spices and 40 g polyphenol rich vegetables (onions, ginger and garlic)
Dose 1, Rice with mixed spices (turmeric, coriander, cumin, gooseberry cayenne pepper, cinnamon, clove), tomatoes, peeled aubergine, onion, ginger and garlic
Active Comparator: Rice with vegetables and high spice
Dose 2 mixed spice session - rice with 12 g powdered mixed spices and 80 g polyphenol rich vegetables (onions, ginger and garlic)
Dose 2, Rice with mixed spices (turmeric, coriander, cumin, gooseberry cayenne pepper, cinnamon, clove), tomatoes, onion, ginger and garlic

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postprandial changes in interstitial glucose concentration
Time Frame: Up to 48 hours from baseline, taken every 5 minutes
Postprandial changes in interstitial glucose concentration using continuous glucose monitoring (CGM) following consumption of increasing doses of mixed spices in a single meal
Up to 48 hours from baseline, taken every 5 minutes
Postprandial changes in plasma insulin concentration
Time Frame: Up to 48 hours from baseline
Postprandial changes in plasma insulin concentration following consumption of increasing doses of mixed spices in a single meal
Up to 48 hours from baseline
Postprandial changes in plasma triglyceride concentration
Time Frame: Up to 48 hours from baseline
Postprandial changes in plasma triglyceride concentration following consumption of increasing doses of mixed spices in a single meal
Up to 48 hours from baseline
Postprandial changes in plasma free fatty acid (FFA) concentration
Time Frame: Up to 48 hours from baseline
Postprandial changes in plasma free fatty acid (FFA) concentration following consumption of increasing doses of mixed spices in a single meal
Up to 48 hours from baseline
Postprandial changes in plasma interleukin-6 (IL-6) concentration
Time Frame: Up to 48 hours from baseline
Postprandial changes in plasma IL-6 concentration following consumption of increasing doses of mixed spices in a single meal
Up to 48 hours from baseline
Postprandial changes in plasma inter-cellular adhesion molecule (ICAM-1) concentration
Time Frame: Up to 48 hours from baseline
Postprandial changes in plasma inter-cellular adhesion molecule (ICAM-1) concentration following consumption of increasing doses of mixed spices in a single meal
Up to 48 hours from baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Monitor changes in blood levels of glucagon like peptide 1 (GLP-1)
Time Frame: Up to 48 hours from baseline
Monitor changes in blood levels of glucagon like peptide 1 (GLP-1) as a result of the mixed spice intake
Up to 48 hours from baseline
Monitor changes in blood levels of glucose dependent insulinotropic peptide (GIP)
Time Frame: Up to 48 hours from baseline
Monitor changes in blood levels of GIP as a result of the mixed spice intake
Up to 48 hours from baseline
Monitor changes in blood levels of peptide YY (PYY)
Time Frame: Up to 48 hours from baseline
Monitor changes in blood levels of PYY as a result of the mixed spice intake
Up to 48 hours from baseline
Monitor changes in plasma metabolome (metabolomics)
Time Frame: Up to 48 hours from baseline
Monitor changes in plasma metabolome including benzoate and hippurate as a result of the mixed spice intake
Up to 48 hours from baseline
Monitor changes in urine metabolome (metabolomics)
Time Frame: Up to 48 hours from baseline
Monitor changes in urine metabolome including hippurate and benzoate as a result of the mixed spice intake
Up to 48 hours from baseline
Monitor changes in gut microbiome
Time Frame: Up to 2 days before and up to 8 days after baseline
Stool samples will be collected at baseline (3 days and 1 day before) and up to 7 days following consumption of curry (1, 3 and 7 days after collection)
Up to 2 days before and up to 8 days after baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 7, 2015

Primary Completion (Actual)

March 26, 2018

Study Completion (Actual)

March 26, 2018

Study Registration Dates

First Submitted

October 23, 2015

First Submitted That Met QC Criteria

November 5, 2015

First Posted (Estimate)

November 6, 2015

Study Record Updates

Last Update Posted (Actual)

October 11, 2018

Last Update Submitted That Met QC Criteria

October 9, 2018

Last Verified

October 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • 2015/00729

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiometabolic Risk

3
Subscribe